IPO - ELUTIA INC.

Form Type: S-3

Filing Date: 2025-03-18

Corporate Action: Ipo

Type: New

Accession Number: 000110465925024551

Filing Summary: Elutia Inc. filed a registration statement with the SEC on March 18, 2025, under Form S-3, to offer and sell up to $100 million of its Class A and Class B common stock, preferred stock, debt securities, warrants, and/or units. The registration statement includes a base prospectus and a sales agreement prospectus related to 'at-the-market' offerings. Elutia aims to utilize the proceeds for general corporate purposes, signaling its phase of growth expansion and market entry. The company, originally known as Aziyo Biologics, Inc., changed its name on September 6, 2023, and operates as an emerging growth company focusing on improving healthcare through innovative biologic solutions. The last reported sale price for its Class A common stock was $3.20 per share on March 17, 2025. Elutia emphasizes the use of a ‘shelf’ registration process to facilitate timely offering and flexibility in accessing the capital markets for future needs.

Document Link: View Document